Last updated on May 2017

Study of Copanlisib in Hepatic or Renal Impairment


Brief description of study

To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects

Clinical Study Identifier: NCT03172884

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

CRS Clinical-Research-Services M nchengladbach GmbH
Mönchengladbach, Germany
  Connect »

Bayer Clinical Trials Contact

CRS Clinical-Research-Services Kiel GmbH
Kiel, Germany
  Connect »